News

B-MoGen Biotechnologies and CytoSen Therapeutics announced a research collaboration to develop the next generation of gene-modified Natural Killer Cell (NK) therapies. B-MoGen will…
Read More...

BioNTech AG, a rapidly growing biotechnology company developing precise and individualized immunotherapies for the treatment of cancer and the prevention of infectious diseases, and MAB…
Read More...

PeptiDream announced that it has entered into a multi-program collaborative research agreement with Osaka-based Shionogi & Co., Ltd for the discovery and development of a series of…
Read More...

Philogen announced through its wholly-owned Swiss subsidiary, Philochem AG, a collaboration agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson…
Read More...

Incyte Corporation announced that the first patient has been treated in GRAVITAS-309, a pivotal Phase 3 trial for the first-line treatment of patients with chronic graft-versus-host…
Read More...

Alvotech announced that it has successfully raised US$300 million through a private bond offering. Net proceeds from the capital raised will be used to fuel continued growth, refinance…
Read More...

Ferring Pharmaceuticals and Karolinska Institutet announced a five-year extension of their collaboration to explore the potential of the human microbiome in reproductive medicine and…
Read More...

Gamida Cell Ltd. and Be The Match BioTherapies, a subsidiary of the National Marrow Donor Program/Be The Match offering integrated platforms and software to manage the collection and…
Read More...

GlaxoSmithKline plc announced that it has successfully completed the acquisition of TESARO, Inc. an oncology-focused company based in Waltham, Massachusetts, for an aggregate cash…
Read More...

Vertex Pharmaceuticals (Europe) Limited announced that the European Commission has granted approval of the label extension for ORKAMBI (lumacaftor/ivacaftor) for the treatment of…
Read More...

Alnylam Pharmaceuticals and Medison Pharma announced an exclusive agreement to commercialize ONPATTRO, the first-ever commercialized RNAi therapeutic, as well as other investigational…
Read More...

Samsung Bioepis Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved ONTRUZANT (trastuzumab-dttb), a biosimilar referencing HERCEPTIN (trastuzumab), across…
Read More...

The Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) today voted eight to eight on the question of whether the overall benefits of…
Read More...

AstraZeneca announced that its partner Ironwood Pharmaceuticals, Inc. has received marketing authorisation from the National Medical Products Administration (NMPA) for Linzess…
Read More...

The SCHOTT technology group is set to invest around 300 million euros in the next three years in the expansion of its core business of glass tubing as the starting material for…
Read More...

AMAG Pharmaceuticals announced that it has completed the previously announced acquisition of Perosphere Pharmaceuticals Inc., a private biopharmaceutical company. Through this…
Read More...

Pfizer Inc. announced that the US Food and Drug Administration (FDA) accepted for filing the company’s New Drug Applications (NDAs) for tafamidis for the treatment of transthyretin…
Read More...

BioMed X announced a new crowdsourcing project within its framework collaboration with Boehringer Ingelheim. BioMed X and Boehringer Ingelheim started their partnership in 2014 and…
Read More...

Aerpio Pharmaceuticals announced the completion of patient dosing in the Company’s TIME-2b study, a Phase 2b clinical trial designed to assess the efficacy and safety of Aerpio’s lead…
Read More...

Zymeworks reported the achievement of a new development milestone in its collaboration with Eli Lilly and Company. In accordance with Zymeworks’ 2014 licensing and collaboration…
Read More...